Drugs / Metformin glycinate
Metformin glycinate
Trials 4 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00960882 | Jun 2007 → Mar 2008 | — | Laboratorios Silanes S.A. de C.V. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00940797 | Jul 2008 → Feb 2009 | type 2 diabetes mellitus | Laboratorios Silanes S.A. de C.V. | Completed | No outcome recorded |
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00940472 | Mar → Dec 2009 | type 2 diabetes mellitus | Laboratorios Silanes S.A. de C.V. | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT01386671 | Jun 2014 → Feb 2016 | type 2 diabetes mellitus | Laboratorios Silanes S.A. de C.V. | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Metformin glycinate | “AIM: This study evaluated the effect of metformin glycinate on glycated hemoglobin A1c (A1C) concentration and insulin sensitivity in drug-naive adult patients with type 2...” PMID 22974412 ↗ Sep 2012 |
| Known as | DMMET-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00940472 ↗ |
| Known as | Glicinato de metformina | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108299 ↗ |
| Known as | Glycinate de metformine | ChEMBL registry synonym — accepted as the source's own label CHEMBL2108299 ↗ |
| Modality | Small molecule | “Metformin glycinate is a new biguanide” NCT01386671 ↗ |